期刊文献+

用重组杆状病毒表达甲型肝炎病毒外壳蛋白 被引量:1

Expression of HAV Capsid Protein in Recombinant Baculoviruse
下载PDF
导出
摘要 应用分子生物学技术 ,将编码甲型肝炎病毒 (HAV )外壳蛋白的开放读码框架 (ORF)全序列插入杆状病毒多角体启动子下游 ,构建成重组杆状病毒 (r BHAV ) ,并在昆虫细胞 SF9中表达。实验证明 ,在该重组杆状病毒中含有完整的 HAV编码序列 (HAV ORF) ;表达的重组蛋白具有良好的抗原性和免疫原性 ;电镜检查被 r BHAV感染的 SF9细胞中有与甲肝病毒颗粒类似的球形结构 ;经氯化铯梯度离心测得该重组蛋白的浮力密度与 HAV空壳一样。 Recombinant baculoviruse was constructed by inserting a full length cDNA open reading frame( ORF) coding HAV capsid protein into the end of polyhedrin promoter and expressed in SF9 cell.The result proved that the recombinant baculoviruse contained a full length HAV ORF,and the expressed protein showed good antigenicity and immunogenicity.HAV particle like spherical structure was observed in the SF9 cells infected with the recombinant baculoviruse under electron microscope.The buoyant density of the recombinant protein detected by cesium chloride gradient centrifugation was similar to that of HAV capsid.
出处 《中国生物制品学杂志》 CAS CSCD 1999年第1期15-17,共3页 Chinese Journal of Biologicals
关键词 甲型肝炎病毒 外壳蛋白 杆状病毒 HAV Capsid protein Baculoviruse
  • 相关文献

参考文献1

  • 1黄桢祥,医学病毒学基础及实验技术,1990年,478页

同被引文献16

  • 1俞瑞纲,刘桂香,姚光弼.甲型肝炎暴发流行47例死亡病例分析[J].上海医学,1989,12(2):81-82. 被引量:2
  • 2OttJ J, Irving G, Wiersma sr. Long-term protective effects of hepatitis A vaccines. A systematic review[J]. Vaccine, 2012,31 (1): 3-11.
  • 3Knipe D, Peter M. Chapter 7: Hepatitis A virus. Fields Virology[M]. 5th Edition. 2007: 937.
  • 4Chung CY, Chen CY, Lin SY, et ol. Enterovirus 71 virus-like particle vaccine: improved production conditions for enhanced yield[Jl. Vaccine, 2010, 28 (43): 6951-6957.
  • 5Kushnir N, Streatfield SJ, Yusibov V. Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development[J]. Vaccine, 2012, 31 (1): 58-83.
  • 6Buonaguro L, Tagliamonte M, Tomesello ML, et ol. Develop?ments in virus-like particle-based vaccines for infectious disea?ses and cancer[J]. Expert Rev Vaccines, 2011,10 (11): 1569- 1583.
  • 7Roldao A, Mellado MC, Castilho LR, et ol. Virus-like particles in vaccine development[J]. Expert Rev Vaccines, 2010, 9 (10): 1149-1176.
  • 8Tagliamonte M, Visciano ML, Tomesello ML, et al. HIV-Gag VLPs presenting trimeric HIV-l gp140 spikes constitutively expressed in stable double transfected insect cell line[J]. Vaccine, 2011, 29 (31): 4913-4922.
  • 9Margine I, Martinez-Gil L, Chou YY, et al. Residual baculovirus in insect cell-derived influenza virus-like particle preparations enhances immunogenicity[J]. PLoS One, 2012, 7 (12): e51559.
  • 10Rosen E, Stapleton IT, McLinden 1. Synthesis of immunogenic hepatitis A virus particles by recombinant baculoviruses[J]. Vaccine, 1993, 11 (7): 706-712.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部